Meloxidyl

Meloxicam, the active ingredient in Meloxidyl, is a oxicam class nonsteroidal anti-inflammatory drug presented as a tablet for oral use. It is indicated for the relief of pain and inflammation associated with osteoarthritis, rheumatoid arthritis and acute musculoskeletal conditions in adult patients.

GNH USA supplies Meloxidyl as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand. Customers benefit from reliable logistics and comprehensive documentation for import compliance.

Meloxicam is used to manage inflammatory and painful conditions within the musculoskeletal disease spectrum. - Osteoarthritis: reduces joint pain, stiffness and improves functional mobility, allowing better daily activity. - Rheumatoid arthritis: alleviates chronic synovial inflammation, joint swelling and pain, helping to slow functional decline. - Acute musculoskeletal pain: provides rapid analgesic effect for pain related to sprains, strains, bruises or postoperative discomfort.

Meloxicam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Peripheral edema: mild swelling of the lower limbs. - Skin rash: mild erythema or pruritus.

Serious or Rare Side Effects: - Peptic ulcer disease or gastrointestinal bleeding. - Severe hepatic injury: jaundice or elevated liver enzymes. - Renal impairment: acute kidney injury or reduced urine output. - Cardiovascular events: myocardial infarction or stroke. - Anaphylaxis: severe allergic reaction with airway compromise.

Before prescribing meloxicam, clinicians should evaluate patient risk factors and follow safety guidelines. - Renal function: assess baseline kidney function and monitor during therapy. - Hepatic status: avoid use in patients with active liver disease or elevated transaminases. - Cardiovascular risk: use cautiously in individuals with hypertension, heart failure or history of thrombotic events. - Gastrointestinal history: consider gastroprotective agents for patients with prior ulcers or bleeding. - Concomitant NSAIDs or anticoagulants: increase risk of bleeding; avoid combined use when possible. - Pregnancy and lactation: avoid unless benefits outweigh potential risks; consult obstetric guidance. - Store at ambient temperature: keep below 25 °C, in original packaging, protected from moisture and light.

Meloxicam can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - High‑dose aspirin or other NSAIDs: additive gastrointestinal toxicity. - Selective COX‑2 inhibitors: heightened cardiovascular risk.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal function, especially in dehydrated patients. - Diuretics: potential for decreased renal perfusion and electrolyte imbalance. - Lithium: NSAIDs can raise lithium serum levels, risking toxicity. - Methotrexate: reduced clearance may increase toxicity. - SSRIs or SNRIs: modest increase in bleeding risk.